Viewing Study NCT00542893


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-02-20 @ 1:41 PM
Study NCT ID: NCT00542893
Status: COMPLETED
Last Update Posted: 2012-03-13
First Post: 2007-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
Sponsor: Genta Incorporated
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bcl-2 View
None CFR View
None DTIC View
None ECOG View
None EMEA View
None MedDRA View
None NCI CTC View
None SAE View